Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Raynaud's Phenomenon.

Literature DB >> 27509103

Raynaud's Phenomenon.

Fredrick M Wigley¹, Nicholas A Flavahan¹.

Abstract

Mesh：

Substances：

Year: 2016 PMID： 27509103 DOI： 10.1056/NEJMra1507638

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

46 in total

1. [Raynaud's phenomenon : Practical management for dermatologists].

Authors: Christian Drerup; Jan Ehrchen
Journal: Hautarzt Date: 2019-02 Impact factor: 0.751

2. Severe Raynaud's phenomenon and Sjögren's syndrome with ferocious gangrene change and auto-amputation.

Authors: Pin-Hsiang Huang; Hsien-Tzung Liao; Chang-Youh Tsai
Journal: Clin Med (Lond) Date: 2019-01 Impact factor: 2.659

3. The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors: Ricardo J Bello; Carisa M Cooney; Eitan Melamed; Keith Follmar; Gayane Yenokyan; Gwendolyn Leatherman; Ami A Shah; Fredrick M Wigley; Laura K Hummers; Scott D Lifchez
Journal: Arthritis Rheumatol Date: 2017-06-26 Impact factor: 10.995

Review 4. Non-Atherosclerotic Vascular Disease in Women.

Authors: Lee Joseph; Esther S H Kim
Journal: Curr Treat Options Cardiovasc Med Date: 2017-09-14

5. In Reply.

Authors: Ana-Luisa Stefanski
Journal: Dtsch Arztebl Int Date: 2017-09-29 Impact factor: 5.594

6. An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud's phEnomenon (SUNSHINE survey).

Authors: Francesca Ingegnoli; Nicola Ughi; Graham Dinsdale; Annalisa Orenti; Patrizia Boracchi; Yannick Allanore; Ivan Foeldvari; Alberto Sulli; Maurizio Cutolo; Vanessa Smith; Ariane L Herrick
Journal: Rheumatol Int Date: 2017-09-11 Impact factor: 2.631

Raynaud's Phenomenon.

1. [Raynaud's phenomenon : Practical management for dermatologists].

2. Severe Raynaud's phenomenon and Sjögren's syndrome with ferocious gangrene change and auto-amputation.

3. The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Review 4. Non-Atherosclerotic Vascular Disease in Women.

5. In Reply.

6. An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud's phEnomenon (SUNSHINE survey).

Review 7. Evidence-based management of Raynaud's phenomenon.

8. Systemic sclerosis: severe pulmonary arterial hypertension and pericardial effusion at diagnosis.

9. Non-invasive digital thermal monitoring and flow-mediated dilation in systemic sclerosis.

10. [Raynaud's phenomenon : Practical management].